Wolverine Asset Management’s Abiomed Inc ABMD Stock Holding History

Wolverine Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-121	Closed	-$37K	–	2558
2021 Q2	$37K	Sell	121 -1,739	-93%	-$533K	﹤0.01%	1758
2021 Q1	$592K	Buy	+1,860	New	+$595K	0.01%	850
2020 Q4	–	Sell	-81	Closed	-$22K	–	1957
2020 Q3	$22K	Buy	+81	New	+$23.3K	﹤0.01%	1392
2020 Q2	–	Sell	-919	Closed	-$133K	–	1841
2020 Q1	$133K	Buy	+919	New	+$153K	﹤0.01%	991
2019 Q2	–	Sell	-3,857	Closed	-$1.1M	–	1644
2019 Q1	$1.1M	Buy	3,857 +1,050	+37%	+$349K	0.02%	618
2018 Q4	$912K	Sell	2,807 -3,116	-53%	-$1.08M	0.01%	849
2018 Q3	$2.66M	Buy	+5,923	New	+$2.33M	0.03%	466
2018 Q2	–	Sell	-2,510	Closed	-$730K	–	1644
2018 Q1	$730K	Buy	+2,510	New	+$636K	0.01%	874

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wolverine Asset Management's ABMD Position: Q3 2021 in Review

Wolverine Asset Management sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 121 shares — an estimated $37K sold.

Wolverine Asset Management first reported a position in ABMD in Q1 2018 and held it in 8 quarters. The position peaked at $2.66M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Wolverine Asset Management reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
Wolverine Asset Management sold 121 Abiomed Inc shares in Q3 2021, an estimated $37K.
Wolverine Asset Management first reported a position in Abiomed Inc in Q1 2018 and held it in 8 quarters.
Wolverine Asset Management's Abiomed Inc position peaked at $2.66M in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.